He. De Vries et al., Oxidized low-density lipoprotein as a delivery system for photosensitizers: Implications for photodynamic therapy of atherosclerosis, J PHARM EXP, 289(1), 1999, pp. 528-534
Citations number
35
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Photodynamic therapy is a promising new strategy in the treatment of cardio
vascular diseases. Photodynamic therapy for vascular diseases may be improv
ed by the specific delivery of photosensitizers to the atherosclerotic lesi
on. In this study, we studied whether oxidatively modified low-density lipo
protein (OxLDL) could be used as a specific carrier for photosensitizers, t
hereby using the scavenger receptor expressed on macrophages as a target. T
he photosensitizer aluminum phthalocyanine chloride (AlPc) was incorporated
into OxLDL, and its photodynamic effects were studied. Macrophages (RAW 26
4.7) were incubated with various concentrations of OxLDL-AlPc for different
periods. After illumination of the cells with red right, cytotoxicity was
observed that was dependent on the time of illumination and incubation. Mac
rophages incubated with OxLDL-AlPc that were not illuminated revealed no cy
totoxicity; The uptake of the OxLDL-AlPc complexes was mediated by scavenge
r receptors expressed on macrophages. In the presence of the polyanion poly
inosinic acid, a specific ligand for scavenger receptors,no cytotoxicity co
uld be observed. Serum incubations of the OxLDL-AlPc complexes revealed tha
t these complexes stay intact after incubation. No redistribution of AlPc t
o other plasma (lipo-) proteins could: be detected, and 80-90% of the AlPc
remained associated with the OxLDL particle. These results indicate that Ox
LDL may function as a specific delivery system for photosensitizers to the
scavenger receptors expressed on the macrophages in the atherosclerotic les
ion, increasing the beneficial effects of photodynamic therapy for cardiova
scular diseases.